Anti-VEGF drugs for retinal diseases could have serious side effects, scientis... (ritical. She and her laboratory mimicked...)

Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution

Date:11/3/2008

ritical. She and her laboratory mimicked the action of the anti-VEGF drugs by introducing into adult mice a soluble VEGF receptor, known as sFlt1, which binds and neutralizes the VEGF-- in much the same way that Lucentis does in the eye.

After two weeks, the team found no effect on blood vessels of the inner retina, but did find a significant increase in the number of dying cells of the inner and outer nuclear layers which include amacrine cells that participate in transmitting the visual signal; Muller cells that also participate in the visual signal and support the photoreceptors; and, photoreceptors, which are responsible for color and night vision. The team then used electroretinograms to measure visual function and found a significant loss in visual function. Consistent with these observations, they discovered that both photoreceptors and Muller cells express VEGFR2, the major VEGF signaling receptor and they found that neighboring Muller cells express VEGF.

Parallel studies in tissue culture demonstrated that suppressing VEGF in Muller cells led to Muller cell death, indicating an autocrine role for VEGF in Muller cells (i.e. Muller cells both make VEGF and use it for survival). Further, they used cultures of freshly isolated photoreceptors to show that VEGF can act as a protectant for these cells.

"Insight into the complex role of VEGF in the eye and in other parts of the body indicates that increased care should be taken in the long-term use of these drugs and that this new information should be considered in the design of future clinical studies to ensure that these possible side effects are taken into account," says D'Amore.

"Mice eyes differ from human eyes in many ways, so we cannot directly extrapolate these results to humans, but this study is an important heads-up that clinical application of anti-VEGF therapy in the eye needs to proceed with caution," she adds.

From a clinical perspective, Dr. Del
'/>"/>

Contact: Patti Jacobs
pjacobs12@comcast.net
617-864-2712
Schepens Eye Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
2. New review suggests caution on drugs to raise good cholesterol
3. Can cancer drugs combine forces?
4. Study provides hope that some transplant patients could live free of antirejection drugs
5. Study provides hope that some transplant patients could live free of anti-rejection drugs
6. RA Drugs Linked to Slight Skin Cancer Risk
7. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
8. Rock N Roll: Sex, Drugs and an Early Exit
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?

Post Your Comments:

(Date:12/15/2009)... cardiovascular event, suicide goes up within a week ... 15 (HealthDay News) -- Emotional stress can put ... for cardiovascular events and suicide, a new study ... Swedish men diagnosed with prostate cancer between 1961 ... experienced a cardiovascular event within a year of ...

(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, In-Vitro ... U.S. and its International Trade [Q4 ... ,, The newly published In-Vitro ... the latest market research on the ...

(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...

(Date:12/15/2009)... STAMFORD, Conn., Dec. 15 Aon ... of Aon Corporation (NYSE: AON ... the firm as senior vice president with ... of the national Pharmacy Practice. ,, ... her new role, Zeitel will work under ...

(Date:12/15/2009)... Ill. and CHENNAI, India, Dec. 15 /PRNewswire-FirstCall/ ... ), the world leader in generic injectable ... (BSE: 524372, NSE: ORCHIDCHEM), a leading Indian ... beta-lactam antibiotics manufacturers globally, today announced an ... injectable finished-dosage form pharmaceuticals business for approximately ...

[0] Stress From Prostate Cancer Diagnosis May Be Fatal [0] Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition][0] Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Aon Consulting Adds Senior Vice President to National Pharmacy Practice [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business

... increases 88% and net premiums written increase 22% over the ... comparable year-earlier quarterly results, FARMINGTON, ... or "Our") (NYSE:,DR) today announced its financial results for the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20060829/NETU014LOGO ), -- Gross ...

... Rights to Bystolic(TM) (Nebivolol) for $370 Million in Cash ... To Consider a Sale of Dey Specialty Business, PITTSBURGH, Feb. ... results for the three and nine months ended,December 31, 2007, provided ... announced a number of strategic and operational,initiatives., Financial Highlights, ...

... Offers Unique Formulation of Important Cancer Medication -, ... Inc.,(NYSE: HSP ), the world leader in ... hydrochloride injection in the United,States. The medication is ... U.S. sales of more than $545 million. Irinotecan ...

... board of trustees approved a proposal today to create ... pharmacy program will serve a total of 300 students ... of 2010., The proposal, which was presented to ... two years of research and study conducted by,members of ...

... Dr. Shawn Hook of Arbor Ridge,Clinic in Madison, Wisconsin ... Great Vectra 3D(TM)" $125,000 Giveaway. Dr. Hook is the,first ... in,medical equipment for his veterinary clinic. There will be ... March, and a final grand prize,winner who will win ...

... WASHINGTON, Feb. 27 Children with special,needs will ... environment levels in,District households. Health Services for Children ... Safe D.C., has begun offering free,in-home lead testing ... needs. The collaboration will initially focus on children ...

Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter Hospira Launches Generic Irinotecan Injection PC Trustees Vote to Start New Pharmacy School in S.C.Summit VetPharm Announces First Winner in its 'Great Vectra 3D(TM)' $125,000 Giveaway Lead Safe D.C. and HSCSN Bring Lead Poisoning Prevention to The District's Children With Special Needs

(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Market Forecasts to 2015, Competitive Benchmarking, ... ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, ... released its latest research "The Future ...

(Date:12/15/2009)... 15 NxStage Medical, Inc. (Nasdaq: ... products, today announced that a group of its ... embarking on a week-long, conventional (non-dialysis) Caribbean cruise ... cruise, dubbed the "2010 Freedom Cruise: We,re Taking ... on January 3, 2010 and returns on January ...

(Date:12/15/2009)... Today, Hill-Rom Holdings, Inc. (NYSE: ... on significant strategic and financial initiatives at its ... Conference is hosted by Peter H. Soderberg, president ... on the following topics: ,, Status of ... development and financial updates Smart technologies that ...

[0] Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)[0] Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies

... HOUSTON, July 9, 2007 - A molecularly ... that shrinks,or eradicates tumors, inhibits metastasis, and prolongs ... of,Texas M. D. Anderson Cancer Center report in ... vehicle, or vector, is so targeted and robust ...

... July 10, 2007 /PRNewswire-FirstCall/ - Bradmer,Pharmaceuticals Inc., ... commercialization of cancer therapies, today,announced that new ... Switzerland validates tenascin as an important molecular,target ... glioblastoma,multiforme (GBM). , The researchers identified that ...

Other Medicine Technology:Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 2 Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 3 Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 4 Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 5 Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 2 Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 3 Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 4

Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings

... allows you to tailor to your specialty. ... Synchronous Processing Technology. The technology delivers a ... all operational modes. Advanced Digital Signal architecture ... voltage over 450,000 times per second and ...

... based adhesive supplied as a phase ... a liquid substrate and crosslinker useful ... When combined the materials ... prepared wound and tenaciously adhere to ...

The DuraSeal System includes an innovative polyethylene glycol hydrogel sealant and applicator packaged in a single-use kit which can be stored at room temperature for convenience and quick preparati...

... DERMABOND* Topical Skin Adhesive gives you new ... is intended for topical application only to ... wounds from surgical incisions, including punctures from ... trauma-induced lacerations. DERMABOND adhesive may be used ...

Medicine Products:

The System 5000 PoliPhase®DuraSeal Dural Sealant DERMABOND

Anti-VEGF drugs for retinal diseases could have serious side effects, scientis...(ritical. She and her laboratory mimicked...),Health